The Column Group
Company: The Column Group
Description: The Column Group (TCG) is a science-driven venture capital firm that focuses on making substantial financial and operational commitments to foster the growth of early-stage drug discovery companies. TCG is distinguished by its unique investment strategy, which prioritizes the development of companies based on their innovative scientific platforms and their potential to deliver a range of transformative therapeutics. This approach contrasts sharply with the prevailing trend in life sciences venture capital, which often emphasizes the assembly of diversified portfolios featuring later-stage, single-product companies that are positioned near value inflection points and potential pharmaceutical buyers.
In taking a long-term perspective, TCG acknowledges that it often requires considerable time to realize significant value in the life sciences sector. The firm's mission is not centered around building businesses solely for exit opportunities. Instead, TCG focuses on the fundamental strength of their portfolio companies, recognizing that key variables—which may include scientific advancements, competitive dynamics, regulatory landscapes, and shifting priorities within the pharmaceutical industry—can evolve rapidly. The firm is dedicated to constructing companies from the ground up, rooted in robust scientific foundations and the capability to create numerous differentiated product opportunities.
Rather than adopting a diversified investment approach, TCG emphasizes a concentrated focus, believing that the most crucial resources—such as innovative ideas, exceptional founders, and elite managerial and scientific talent—are indeed rare. By concentrating these resources within a select group of companies, TCG aims to enhance the potential for success. The firm's philosophy is marked by the bold pursuit of ambitious ideas, leveraging innovative scientific advancements to develop breakthrough therapies that address significant health challenges.
Committed to all aspects of company building, The Column Group integrates a wealth of scientific, financial, and operational expertise to transform promising scientific concepts into a valuable portfolio with the potential to make a substantial impact on human health. Through its focused approach, TCG aspires to contribute to the next generation of highly effective human therapies, ultimately advancing the landscape of drug discovery and development.
Industry: Venture Capital and Private Equity
Domain: http://www.thecolumngroup.com/
Location: San Francisco, CA
Address: San Francisco, CA, US
Size: 11-50 employees
Direct Contacts
Name: Sue Murakami
Title: Operations Manager
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Francisco, California
Name: Irene Chen
Title: Swanson Fellow
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Francisco, California
Name: Peter Svennilson
Title: Managing Partner and Founder
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Francisco, California
Name: Tim Kutzkey
Title: Managing Partner
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Francisco, California
Name: David Liu
Title: Assistant Controller
Email: Direct Email
Company: The Column Group
LinkedIn: http://www.linkedin.com/in/dtliu
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Francisco, California
Name: Jonathan Karr
Title: Swanson Fellow
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: Berkeley, California
Name: Carla Daniel
Title: Vice President & Head of Talent
Email: Direct Email
Company: The Column Group
LinkedIn: http://www.linkedin.com/in/danielcarla
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: Oakland, California
Name: Matt Callahan
Title: Swanson Fellow
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Francisco, California
Name: Nathan Levy
Title: Tax and Accounting
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Francisco, California
Name: Kristen Hunter
Title: Portfolio Accounting Manager
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Francisco, California
Name: Karina Tin
Title: Technology & Media Manager
Email: Direct Email
Company: The Column Group
LinkedIn: http://www.linkedin.com/in/karinatin
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Francisco, California
Name: Hui Tian
Title: Partner
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Mateo, California
Name: James Evangelista
Title: Partner & Chief Financial Officer
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: San Francisco, California
Name: Larry Lasky
Title: Partner
Email: Direct Email
Company: The Column Group
Phone: (415)-865-2050
Industry: Venture Capital and Private Equity
Location: Sausalito, California